Lung Cancer

HomePatientsLung Disease Week at the ATS2012Lung Cancer ▶ Information for Experts
Information for Experts

Lung Cancer Week at the ATS

Lung
Research Grants

The NLCP has funded over $3 million in research since 2005. Learn about previous grants and find upcoming grant opportunities.

More Info

Lung
Access TLC

This project is designed to better understand when and why treatment delays occur so we can create effective programs for health care providers to improve patient care. Participant recruitment is currently underway in North Carolina and Wisconsin.

More Info

Lung
Lung Cancer Mutation Consortium (LCMC)

This collaboration of 16 leading cancer centers, which the National Lung Cancer Partnership helps coordinate, is the largest national initiative to prospectively examine non-small cell lung cancer tumors and match patients to the best possible therapies.

Click Here

Lung
Professional Events

Find events, conferences, and CME programs related to lung cancer diagnosis, treatment, and care.

More Info

Clinician
ATS Educational Products 2012

- A12 - DISCUSSION ON THE EDGE: REPORTS OF RECENT PULMONARY RESEARCH PUBLISHED IN THE NEW ENGLAND JOURNAL OF MEDICINE AND THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

- A81 - SCIENTIFIC BREAKTHROUGHS SYMPOSIUM: BIOMARKERS FOR LUNG DISEASE: THE CUTTING EDGE

- B83 - IMMUNOTHERAPY FOR LUNG CANCER AND MESOTHELIOMA

- C10 - IMPLEMENTING LUNG CANCER SCREENING: MOVING FROM RCTS TO THE REAL WORLD

- C88 - LUNG CANCER STEM CELLS AND THE ROLE OF THE MICROENVIRONMENT IN LUNG CARCINOGENESIS

- PG3 - LUNG CANCER: STATE OF THE ART IN 2012 

(For Best of ATS Conferences materials visit the following link : https://cms.psavcns.com/library/ats)


Clinician
ATS Educational Products 2011

- A02 - ADVANCES IN STAGE III AND IV LUNG CANCER

- A92 - LUNG CANCER SCREENING: WHAT WE HAVE LEARNED FROM THE NATIONAL LUNG SCREENING TRIAL (NLST) AND WHAT WE STILL NEED TO KNOW.

- C81 - SCIENTIFIC BREAKTHROUGHS OF THE YEAR: PROGRESS IN LUNG TISSUE ENGINEERING

- D04 - LONG TERM OUTCOMES AFTER THE INTENSIVE CARE UNIT

- PG13 - ENGINEERED NANOPARTICLES AND AIRWAY: THERAPEUTIC APPLICATIONS AND HEALTH RISKS 

- PG18 - LUNG CANCER IN 2011: THE STATE OF THE ART

For Best of ATS Conferences materials visit the following link : https://cms.psavcns.com/library/ats


Clinician
ATS Journal articles on Chronic Obstructive Pulmonary Disease (select abstracts listed below) 

Lung Cancer: AJRCCM

Doubling Times and CT Screen–Detected Lung Cancers in the Pittsburgh Lung Screening Study
Read Abstract
Volume 185; January 1, 2012

Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease: Incidence and Predicting Factors
Read Abstract
Volume 184; October 15, 2011

Familial Lung Cancer: Genetic Susceptibility and Relationship to Chronic Obstructive Pulmonary Disease
Read Abstract
Volume 173; September 1, 2006

Association of Radiographic Emphysema and Airflow Obstruction with Lung Cancer
Read Abstract
Volume 178; October 1, 2008

Plasma DNA Quantification in Lung Cancer Computed Tomography Screening: Five-Year Results of a Prospective Study
Read Abstract
Volume 179; January 1, 2009

Lung Cancer and Lung Stem Cells: Strange Bedfellows?
Read Abstract
Volume 175; March 15, 2007

Lung Cancer-Where Are We Today?: Current Advances in Staging and Nonsurgical Treatment
Read Abstract
Volume 166; November 1, 2002

Expression of IL-32 in Human Lung Cancer Is Related to the Histotype and Metastatic Phenotype
Read Abstract
Volume 180; October 15, 2009

An Official American Thoracic Society Systematic Review: Insurance Status and Disparities in Lung Cancer Practices and Outcomes
Read Abstract
Volume 182; November 1, 2010

Lung Cancer: AJRCMB

S-Nitrosoglutathione Reductase in Human Lung Cancer
Read Abstract
Volume 46; January 2012

Monocyte Chemoattractant Protein–1 Blockade Inhibits Lung Cancer Tumor Growth by Altering Macrophage Phenotype and Activating CD8+ Cells
Read Abstract
Volume 44; February 2011

Wound Healing after Trauma May Predispose to Lung Cancer Metastasis: Review of Potential Mechanisms
Read Abstract
Volume 44; May 2011

Asbestos, Lung Cancers, and Mesotheliomas: From Molecular Approaches to Targeting Tumor Survival Pathways
Read Abstract
Volume 42; February 2010

Gene Therapy for Mesothelioma and Lung Cancer
Read Abstract
Volume 42; April 2010

Early Manifestations of NNK-Induced Lung Cancer: Role of Lung Immunity in Tumor Susceptibility
Read Abstract
Volume 36; January 2007

Proliferative Stimulus of Lung Fibroblasts on Lung Cancer Cells Is Impaired by the Receptor for Advanced Glycation End-Products
Read Abstract
Volume 34; January 2006

Pathogenesis of Lung Cancer: 100 Year Report
Read Abstract
Volume 33; September 2005

Lung-Specific Expression of Dominant-Negative Mutant p53 in Transgenic Mice Increases Spontaneous and Benzo(a)pyrene-Induced Lung Cancer
Read Abstract
Volume 27; August 2002

Lung Cancer: PATS

Lung Cancer Chemoprevention
Read Abstract
Volume 9; May 1, 2012

Chronic Obstructive Pulmonary Disease and Lung Cancer: Common Pathogenesis, Shared Clinical Challenges
Read Abstract
Volume 9; May  1, 2012

New Approaches to Targeted Therapy in Lung Cancer
Read Abstract
Volume 9; May 1, 2012

Field Cancerization in Non–Small Cell Lung Cancer: Implications in Disease Pathogenesis
Read Abstract
Volume 9; May 1, 2012

Pathway-Based Classification of Lung Cancer: A Strategy to Guide Therapeutic Selection
Read Abstract
Volume 8; May 1, 2011

Genomics of Lung Cancer
Read Abstract
Volume 6; April 15, 2009

Immunotherapy for Lung Cancer
Read Abstract
Volume 6; April 15, 2009